Senior Manager / Associate Director, Site Activation

This is a fully remote position, open to applicants in United States.

📋 Description

• Create and implement strategic account plans targeting health systems, integrated delivery networks (IDNs), and treatment centers.

• Oversee the activation, onboarding, contracting, operational readiness, and certification processes for treatment centers.

• Act as the main point of contact for CAR-T/cell therapy operations, including logistics and order management.

• Collaborate across various functions such as Sales, Marketing, Medical Affairs, Market Access, Patient Services, Supply Chain, Manufacturing, Quality, Finance, Legal, and Commercial Operations to address issues and achieve key performance metrics.

• Assist in developing reimbursement strategies and contracting initiatives.

• Propel expansion efforts that encompass satellite apheresis, outpatient treatment models, and multi-site frameworks.

• Evaluate and track account performance, identify operational deficiencies, and execute continuous improvement measures.

• Provide insights on customer experiences, site performance, and launch readiness during senior-level meetings.

• Cultivate executive relationships and conduct strategic business reviews.

⛳️ Requirements

• A bachelor's degree is mandatory; an advanced degree is preferred.

• Over 8 years of experience in biotechnology, pharmaceuticals, or cell therapy with a proven track record of successful site onboarding.

• Additional experience with specialty biologics and neurology products is advantageous.

• Proven experience managing accounts within health systems, IDNs, or treatment centers.

• Familiarity with cell therapy operations, reimbursement processes, contracting, and Group Purchasing Organizations (GPOs).

• Background in cross-functional collaboration within commercial and medical teams.

• Excellent communication, analytical, negotiation, and executive relationship management abilities.

🏝️ Benefits

• Bonus

• Benefits

• Participation in the Company's stock plan